Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A. Todd, Frank Waldron-Lynch, Antony J. Cutler et al.|PLoS Medicine|2016Cited by 140